Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06680323

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults

The primary objective of this study is the identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA). The secondary objectives are to generate a model integrating the genetic and environmental factors to estimate the risk of developing melanoma and improve the primary prevention of melanoma through evidence-based interpretation of environmental risk.

Recruiting

Interested in participating?

Request Info

Key information

About this study

By retrieving data from several epidemiological and clinical registries across Europe it is aimed to integrate and maximize efforts in order to create a large dataset that serves for a comprehensive analysis of genetic and environmental factors influencing the etiology of melanoma in CAYA. The data will be combined with exposome information about climate and pollution for the development of a weighted risk score. Furthermore, germline high risk mutations and germline low-medium risk variants will be analyzed. Genome and transcriptome sequencing of blood and in selected cases tumour will provide the most comprehensive data to create a polygenic risk score for CAYA melanoma. Transcriptome data will help to identify and characterize the effect of variants of unknown significance in coding, intronic as well as regulatory regions. Tumour sequencing can provide additional information on functional relevance of variants, e.g. secondary hits in tumour tissue or second hits in tumour suppressor genes. Such identification will be highly advantageous to design prevention strategies for melanoma development in CAYA.

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • confirmed melanoma
  • age until 30 years old

Exclusion criteria

  • no available biological material
  • no signed informed consent

Treatment and study plan

Primary outcomes

  1. Identification of environmental and genetic factors involved in the risk and progression of melanoma in children, adolescents and young adults (CAYA)

    Time frame: 01.01.2024 - 30.11.2025

    By retrieving data from several epidemiological and clinical registries across Europe we aim to create a large dataset that serves for a comprehensive analysis of genetic and environmental factors influencing the etiology of melanoma in CAYA. Data on climate variables such as surface temperature, solar radiation, and air pollutants will be collected from ground-based instruments, such as air quality monitoring stations, and satellites and reanalysis data from the Copernicus Atmosphere Monitoring Service (CAMS). Data analysis from genome sequencing will be done using established bioinformatic pipelines and combined with exposome information about climate and pollution for the development of a weighted risk score.

Secondary outcomes

  1. Generating a polygenic risk score for melanoma in CAYA by using the Lindeman-Merenda-Gold (LMG) method

    Time frame: 01.06.2024 - 31.05.2026

    Genome and transcriptome sequencing of blood and in selected cases tumour will provide the most comprehensive data to create a polygenic risk score for melanoma in CAYA.

    We will develop a weighted risk score for each environmental factor, which comprises the effects of several variables measuring the respective risk factor. Additionally, a weighted risk score for the epigenetic variables will be build. To estimate the relative contribution of environmental and epigenetic factors we will calculate the relative importance (proportion of explained variance) of the weighted risk scores in an ordinary linear regression model using the Lindeman-Merenda-Gold (LMG) method.

  2. Prevention strategies for melanoma development in CAYA

    Time frame: 01.06.2025 - 30.09.2026

    The detected risk factors and determinants will be used by health professionals to update clinical guidelines for prevention, screening and early detection of melanoma in CAYA. Health care system strategies will be implemented in European countries overcoming current gaps in European countries on prevention and diagnosis of melanoma in CAYA. The success will be measured by incidence rates of melanoma.

Study contacts

Contact information is provided by the study sponsor or research team.

Christopher Schroeder, MD

CONTACT

[email protected]

Ines B Brecht, MD, PhD

CONTACT

[email protected]

+49707183773

Sponsors and collaborators

Lead sponsor

University Hospital Tuebingen

Other

Collaborators

  • Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
  • Hospital Clinic of Barcelona
  • Karolinska University Hospital
  • Leibniz Research Institute for Environmental Medicine Düsseldorf
  • Medical University of Gdansk
  • Princess Maxima Center for Pediatric Oncology
  • University Of Perugia

Registry information

Official study title

Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults - Novel Health Care Strategies for Melanoma in Children, Adolescents and Young Adults (MELCAYA)

Acronym: ExpoMel

Important dates

Study start
2024
Primary completion
2025
Study completion
2026
First posted
Nov 8, 2024
Registry last updated
Nov 8, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.